7Baggers
Quarterly
Annual
    Unit: USD2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30 2024-03-31 2023-12-31 2023-09-30 2023-06-30 2023-03-31 2022-12-31 2022-09-30 2022-06-30 2022-03-31 2021-12-31 2021-09-30 2021-06-30 2021-03-31 2020-12-31 2020-09-30 2020-06-30 2020-03-31 2019-12-31 2019-09-30 2019-06-30 2019-03-31 2018-12-31 2018-09-30 2018-06-30 2018-03-31 
      
    		                               
      operating activities
    		                               
      net income
    		-72,673,000 -9,283,000 -13,282,000 -15,589,000 -145,183,000 -4,257,000 -24,275,000 -100,836,000 -23,966,000 -23,508,000 13,608,000 -378,279,000 6,267,000 -126,290,000 33,038,000 -11,835,000 -44,529,000 -47,306,000 -24,895,000 -6,777,000 -15,356,000 -19,758,000 -13,531,000 3,427,000 -7,747,000 -6,510,000 -6,314,000 -11,566,000 -8,368,000 -13,053,000 -20,055,000 
      adjustments to reconcile net income to net cash from operating activities:
    		                               
      credit loss expense
    		-51,000 1,190,000 643,000 2,126,000 219,000 2,191,000 1,570,000 551,000 409,000 990,000 -246,000 1,450,000 -92,000 695,000 346,000 262,000 284,000 152,000 1,004,000             
      depreciation and amortization
    		6,473,000 6,275,000 6,291,000 5,940,000 6,970,000 6,529,000 6,250,000 6,695,000 5,990,000 7,200,000 6,575,000 6,849,000 10,468,000 10,356,000 9,871,000 9,598,000 8,375,000 8,833,000 3,065,000 2,017,000 1,933,000 1,545,000 2,331,000 1,354,000 1,167,000 1,053,000 961,000 811,000 777,000 784,000 910,000 
      amortization of financing costs charged to interest expense
    		390,000 399,000 405,000 398,000 385,000 405,000 445,000 414,000 415,000 412,000 407,000 403,000 402,000 388,000 402,000 267,000 253,000 229,000 219,000 22,000 242,000 24,000 24,000 23,000 22,000 23,000 27,000 27,000 26,000 89,000 140,000 
      amortization of right-of-use assets
    		515,000 642,000 632,000  555,000 523,000 549,000  602,000 970,000 1,235,000  1,291,000 1,423,000 1,516,000  1,416,000 1,281,000 1,073,000  908,000 852,000 879,000         
      gain on disposal or divestiture
    		319,000 200,000 -5,350,000                             
      gain on debt extinguishment
    		   0 0                           
      stock-based compensation expense
    		6,422,000 7,501,000 8,694,000 8,673,000 8,065,000 12,644,000 10,985,000 11,024,000 10,249,000 11,739,000 7,968,000 12,492,000 5,767,000 12,842,000 13,585,000 12,849,000 16,830,000 13,337,000 7,248,000 7,585,000 11,578,000 9,108,000 4,125,000 3,585,000 7,486,000 3,072,000 1,708,000     
      impairment of goodwill and intangible assets
    		   0                            
      change in contingent consideration
    		0 42,000 60,000 100,000 101,000 -5,808,000 5,817,000                         
      other non-cash income
    		1,825,000 -5,456,000 -2,620,000 5,617,000 -4,799,000 -4,000 667,000 -3,557,000 2,534,000 -2,242,000 -905,000   4,513,000 1,574,000 68,000 1,554,000 -138,000 -141,000    1,923,000    -235,000 635,000 263,000   
      change in operating assets and liabilities:
    		                               
      accounts receivable
    		4,643,000 2,629,000 7,536,000  -1,874,000 1,460,000 13,323,000  -7,078,000 -3,336,000 21,405,000  -4,581,000 4,384,000 15,279,000  -10,966,000 2,342,000 7,867,000 -27,406,000 -17,450,000 20,311,000 22,149,000 -20,229,000 1,235,000 -11,764,000 4,740,000 -20,309,000 3,182,000 -922,000 8,623,000 
      prepaid expenses and other assets
    		1,395,000 -1,569,000 -56,000 1,589,000 164,000 3,057,000 -3,450,000 1,378,000 684,000 799,000 -369,000 991,000 1,429,000 -1,160,000 -725,000 -170,000 600,000 -51,000 -1,845,000 1,347,000 -809,000 -94,000 -509,000 -856,000 254,000 -449,000 -1,173,000 -478,000 -288,000 11,000 -1,520,000 
      accounts payable
    		1,644,000 -2,388,000 551,000 -321,000 10,000 685,000 125,000 504,000 1,781,000 -355,000 -1,691,000 -1,004,000 1,932,000 -966,000 -855,000 1,218,000 -1,979,000 1,526,000 495,000 -99,000 278,000 -415,000 252,000 -200,000 -95,000 385,000 -691,000 690,000 1,060,000 -431,000 -408,000 
      other accrued expenses
    		842,000 -975,000 1,895,000 -3,452,000 4,061,000 381,000 -7,634,000 2,790,000 672,000 -7,818,000 -3,136,000 -3,702,000 -44,000 5,799,000 -11,569,000 1,721,000 -4,647,000 1,025,000 996,000 5,633,000 51,000 66,000 -6,988,000 4,699,000 1,130,000 2,093,000 -1,770,000 3,231,000 261,000 1,599,000 -1,836,000 
      partner share liability
    		-5,007,000 -2,053,000 -3,860,000 1,980,000 -3,216,000 -1,823,000 -13,291,000 5,399,000 -5,263,000 9,970,000 -9,701,000 7,557,000 -1,015,000 4,779,000 -9,600,000 11,310,000 6,597,000 -2,019,000 -6,749,000             
      consumer incentive liability
    		-3,819,000 4,071,000 -8,245,000  4,331,000 1,464,000 -8,698,000  5,883,000 -328,000 -10,630,000  5,431,000 -2,176,000 -7,503,000  6,364,000 1,242,000 -4,072,000  5,180,000           
      net cash from operating activities
    		1,761,000 1,225,000 -6,706,000 2,979,000 1,385,000 4,429,000 -17,617,000 2,934,000 1,194,000 5,751,000 -10,064,000 -13,101,000 -14,434,000 -6,678,000 -19,691,000  -10,458,000 -14,978,000 -12,532,000   -4,238,000 -3,406,000   -1,486,000 -1,483,000 -4,695,000 -1,515,000 -12,695,000 -90,000 
      capex
    		-4,464,000 -4,658,000 -4,103,000 -4,436,000 -5,257,000 -4,858,000 -4,747,000 -3,697,000 -3,146,000 -2,747,000 -2,802,000 -3,051,000 -3,288,000 -4,261,000 -2,711,000  -2,861,000 -2,921,000 -3,300,000   -1,943,000 -1,414,000   -3,177,000 -1,981,000 -3,148,000 -2,022,000 -1,357,000 -792,000 
      free cash flows
    		-2,703,000 -3,433,000 -10,809,000 -1,457,000 -3,872,000 -429,000 -22,364,000 -763,000 -1,952,000 3,004,000 -12,866,000 -16,152,000 -17,722,000 -10,939,000 -22,402,000  -13,319,000 -17,899,000 -15,832,000   -6,181,000 -4,820,000   -4,663,000 -3,464,000 -7,843,000 -3,537,000 -14,052,000 -882,000 
      investing activities
    		                               
      acquisition of property and equipment
    		-14,000 -322,000 -119,000 -123,000 -507,000 -281,000 -651,000 -274,000 -51,000 18,000 -360,000 -81,000 -201,000 -492,000 -397,000 -963,000 -355,000 -413,000 -1,377,000 -2,717,000 -1,466,000 -733,000 -492,000 -3,716,000 -542,000 -2,527,000 -1,492,000 -2,730,000 -1,698,000 -1,074,000 -418,000 
      capitalized software development costs
    		-4,450,000 -4,336,000 -3,984,000 -4,313,000 -4,750,000 -4,577,000 -4,096,000 -3,423,000 -3,095,000 -2,765,000 -2,442,000 -2,970,000 -3,087,000 -3,769,000 -2,314,000 -2,386,000 -2,506,000 -2,508,000 -1,923,000 -1,114,000 -1,387,000 -1,210,000 -922,000 -876,000 -697,000 -650,000 -489,000 -418,000 -324,000 -283,000 -374,000 
      business divestiture and acquisitions, net of cash acquired
    		0                               
      net cash from investing activities
    		-4,464,000 -4,658,000 -3,903,000 -4,086,000 -5,257,000 -4,656,000 -4,747,000 -1,367,000 -3,146,000 -2,747,000 -2,802,000 -3,153,000 -3,304,000 -4,269,000 -5,034,000 -3,414,000 -2,871,000 -348,448,000 -151,962,000 -3,857,000 -2,873,000 -1,950,000 -1,437,000 -4,609,000 -1,248,000 -3,182,000 -1,981,000 -3,157,000 -2,024,000 -1,367,000 -794,000 
      financing activities
    		                               
      proceeds from issuance of debt
    		   0    0 0 0 30,000,000                 0 0   
      settlement of contingent consideration
    		0 -2,000,000 -3,000,000 0 -1,000 5,908,000 -20,074,000 0 0                       
      principal payment of debt
    		                               
      proceeds from termination of capped calls related to convertible notes
    		   0 0                           
      proceeds from issuance of common stock
    		   11,000 0 0 48,634,000 0 44,000   -18,000 4,000 198,000 195,000 225,000 473,000 977,000 484,713,000 3,805,000 945,000 2,290,000 3,145,000 9,294,000 80,709,000 1,040,000 173,000 155,000 1,652,000 37,000 70,490,000 
      equity issuance costs
    		   0 -119,000                   -158,000    0 -52,000 -665,000 -1,232,000 
      debt issuance costs
    		-12,000 -59,000 -34,000 -201,000 -268,000       7,000 -7,000   0 -114,000 -44,000 -42,000     0 -50,000 -87,000 -6,000 0 0   
      net cash from financing activities
    		-12,000 -2,059,000 -3,034,000 -202,000 -388,000 -26,287,000 28,321,000  21,000 -50,076,000 29,981,000            3,139,000 9,130,000 43,939,000 -9,052,000 162,000 49,000 936,000 -5,026,000 69,232,000 
      effect of exchange rates on cash and cash equivalents
    		-69,000 191,000 95,000                             
      net decrease in cash and cash equivalents
    		-2,784,000                               
      cash and cash equivalents — beginning of period
    		0 0 65,594,000                             
      cash and cash equivalents — end of period
    		-2,784,000 -5,301,000 52,046,000                             
      principal payments of the 2018 line of credit
    		                               
      principal payments of 2020 convertible senior notes
    		                               
      proceeds from issuance of 2024 convertible senior notes
    		                               
      business divestiture
    		  200,000                             
      net increase in cash and cash equivalents
    		  -13,548,000                             
      amortization of right-of-use asset
    		                               
      loss on divestiture
    		                               
      income tax benefit
    		           0 0                   
      accounts receivable and contracts assets
    		                               
      customer incentive liability
    		                      -5,638,000 3,988,000 388,000 268,000 3,741,000 6,646,000 -1,003,000 -1,116,000 -293,000 
      acquisition of patents
    		           -102,000 -16,000 -8,000 -49,000 -65,000 -10,000 -30,000 -28,000 -26,000 -20,000 -7,000 -23,000 -17,000 -9,000   -9,000 -2,000 -10,000 -2,000 
      business acquisitions, net of cash acquired
    		           0                    
      proceeds from divestitures, net of cash divested
    		                               
      principal payments of debt
    		       -10,000 -10,000 -7,000 -4,000 -11,000 -3,000 -8,000 -13,000   -5,000 -6,000 -6,000 -6,000 -5,000 -6,000 -6,000 -36,682,000 -10,005,000 -5,000 -106,000 -664,000 -51,785,000 -26,000 
      repurchase of common stock
    		           0 0                   
      effect of exchange rates on cash, cash equivalents and restricted cash
    		   -85,000 0 -4,000 -21,000 75,000 -74,000 -59,000 176,000 -170,000 -787,000 -335,000 -634,000 -174,000 -275,000 -257,000 139,000 425,000 114,000 96,000 -588,000 536,000 -336,000 -219,000 120,000 -139,000 -53,000 -229,000 175,000 
      net decrease in cash, cash equivalents and restricted cash
    		   -1,394,000 -4,260,000   1,690,000 -2,005,000    -18,531,000         -3,820,000 -2,292,000         
      cash, cash equivalents, and restricted cash — beginning of period
    		   0 0 0 91,830,000 0 0 0 121,985,000 0 0 0 233,562,000 0 0 0 293,349,000 0 0 0 104,587,000 0 0 0 59,870,000 0    
      cash, cash equivalents, and restricted cash — end of period
    		   -1,394,000 -4,260,000 -26,518,000 97,766,000 1,690,000 -2,005,000 -47,131,000 139,276,000 -16,603,000 -18,531,000 -51,266,000 208,385,000 -3,918,000 -13,234,000 -362,945,000 613,659,000 5,601,000 189,273,000 -3,820,000 102,295,000 9,157,000 52,681,000 -13,939,000 56,688,000 -7,942,000    
      deferred equity issuance costs
    		               0 0               
      deferred financing costs
    		      -239,000                         
      net increase in cash, cash equivalents and restricted cash
    		      5,936,000    17,291,000    -25,177,000 -3,918,000   320,310,000 5,601,000    9,157,000 52,681,000 -13,939,000 -3,182,000 -7,942,000 -2,656,000 -19,317,000 68,523,000 
      accretion of debt discount and non-cash interest expense
    		               2,435,000 2,398,000 2,359,000 2,321,000         0 0 826,000 1,500,000 
      change in fair value of contingent consideration
    		          -34,584,000 -14,030,000 -46,126,000 -2,968,000 -65,050,000 -6,367,000 6,261,000               
      deferred implementation costs
    		               1,442,000                
      net cash (used in) received from financing activities
    		                               
      goodwill impairment
    		            0                   
      (gain) loss in fair value of contingent consideration
    		                               
      deferred debt costs
    		        -13,000 -30,000 -15,000                     
      gain in fair value of contingent consideration
    		                               
      proceeds from issuance of convertible senior notes, net of issuance costs paid of 6,900
    		                               
      purchase of capped calls related to convertible senior notes
    		                   0            
      net cash received from (used in) financing activities
    		                               
      other non-cash expense
    		                    -907,000    1,431,000       
      net cash received provided by financing activities
    		                               
      business acquisition, net of cash acquired
    		             0 -2,274,000  0 -345,497,000 -148,634,000             
      net cash received from financing activities
    		              182,000 225,000 370,000 738,000 484,665,000             
      recovery of deferred implementation costs
    		                               
      net cash received from (used in) operating activities
    		                               
      amortization of deferred implementation costs
    		                 730,000 882,000             
      change in the fair value of warrant liabilities
    		                           0 -801,000 -1,611,000 9,172,000 
      amortization and impairment of deferred fi implementation costs
    		                   958,000            
      settlement of paid-in-kind interest
    		                           0 -42,000   
      deferred fi implementation costs
    		                           -3,500,000 -3,500,000 -3,344,000 1,094,000 
      recovery of deferred fi implementation costs
    		                       1,156,000 1,157,000 1,155,000 1,157,000 1,344,000 1,344,000   
      fi share liability
    		                   10,980,000 7,186,000 -11,757,000 -10,908,000 8,260,000 3,109,000 7,219,000 -4,287,000 7,470,000 -543,000 -647,000 -2,538,000 
      proceeds from issuance of convertible senior notes
    		                               
      bad debt expense
    		                    -45,000 -151,000 1,477,000         
      amortization of deferred fi implementation costs
    		                     991,000 1,008,000 696,000 789,000 731,000 653,000     
      change in the fair value of convertible promissory notes
    		                               
      change in the fair value of convertible promissory notes - related parties
    		                               
      proceeds from issuance of series g preferred stock
    		                               
      change in fair value of warrant liabilities
    		                               
      net cash (used in) from operating activities
    		                               
      supplemental schedule of non-cash investing and financing activities:
    		                               
      amounts accrued for property and equipment
    		                         -1,093,000 1,146,000 -1,057,000 472,000 70,000 1,155,000 
      amounts accrued for capitalized software development costs
    		                            -77,000 -55,000 141,000 
      termination of u.k. agreement expense
    		                               
      payable to related party
    		                               
      proceeds from issuance of debt—related parties
    		                               
      debt extinguishment costs
    		                               
      stock-based compensation
    		                               
      cash flows from operating activities:
    		                               
      change in allowance for doubtful accounts
    		                             16,000 -32,000 
      stock compensation expense
    		                             8,345,000 2,900,000 
      total adjustment
    		                             358,000 19,965,000 
      cash flows from investing activities:
    		                               
      cash flows from financing activities:
    		                               
      cash, cash equivalents and restricted cash—beginning of period
    		                             0 21,262,000 
      cash, cash equivalents and restricted cash—end of period
    		                             -19,317,000 89,785,000 
      cash paid for interest
    		                             8,457,000 247,000 
      stock-based compensation capitalized for software development
    		                             0 6,000 
      other non-cash expenses
    		                              2,253,000 
      increase in allowance for doubtful accounts
    		                               
      depreciation and amortization expense
    		                               
      accretion of debt discount charged to interest expense
    		                               
      change in fair value of warrant liability
    		                               
      change in fair value of convertible promissory notes
    		                               
      change in fair value of convertible promissory notes—related parties
    		                               
      acquisition of intangible assets
    		                               
      proceeds from issuance of debt — related parties
    		                               
      cash, cash equivalents and restricted cash — beginning of period
    		                               
      cash, cash equivalents and restricted cash — end of period
    		                               
    The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.